Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **casein phosphopeptide-amorphous calcium phosphate complex (CPP-ACP)** is a nano-sized aggregate formed from tryptic digestion of casein milk proteins, yielding phosphopeptides that stabilize calcium and phosphate ions in an amorphous, highly bioavailable structure[1][2][4]. CPP-ACP is used in dental and nutritional products to promote enamel remineralization and intestinal calcium absorption by preventing mineral precipitation and facilitating uptake[1][2][4][5]. While extensively studied for dental caries prevention and as a supplement for bone health, the complex is not a classical molecular target in drug discovery but a bioactive ingredient or delivery vehicle in food and dental science[5][7]. The composition, typically derived from bovine milk, makes it suitable for most populations, with research supporting its role in enhancing mineral bioavailability and remineralization processes in vivo[4][5][7].
Mineral ion stabilization and delivery via peptide binding
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Casein phosphopeptide-amorphous calcium phosphate complex (CPP-ACP).